Physician

Abdullateef Abdulkareem, M.D.

According to 2025 Medicare claims, Abdullateef Abdulkareem, M.D. (NPI: 1386027068) practices hematology/oncology in the Lancaster, PA market, with the plurality of this provider's patient population coming from Lancaster, PA. This provider's primary affiliated billing organization is LANCASTER GENERAL MEDICAL GROUP (NPI: 1376526152; TIN: 232777286) and primary practice location at 17601-2644. Abdulkareem is affiliated with the Lancaster General Health Community Care Collaborative, LLC (ACO ID: A2019), participating under the MSSP model.

Abdulkareem's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 302 traditional Medicare patients, billed 778 HCPCS/CPT codes, and received $71,890 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 974 prescription claims across 141 beneficiaries totaling $3,933,585 in drug costs, led by Brukinsa (Zanubrutinib). DME data shows 89 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $3,435 to $3,933,585. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	199	558	$52,327
2019	254	715	$64,309
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	99	193	$21,875
2023	247	702	$72,343
2024	302	778	$71,890

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	25	$3,435
2016	33	66	$11,588
2017	22	124	$11,696
2018	70	169	$18,975
2019	67	207	$4,780
2020	23	48	$44,063
2021	25	67	$46,676
2022	39	136	$150,446
2023	104	617	$1,507,112
2024	141	974	$3,933,585

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	52	$375
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	53	$1,356
2024	N/R	89	$2,243

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	85	245	$128
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	58	58	$119
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	30	31	$96
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	115	186	$86
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	83	101	$62

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Brukinsa	Zanubrutinib	48	1,440	$626,041
Bosulif	Bosutinib	24	720	$473,897
Revlimid	Lenalidomide	17	434	$290,899
Cabometyx	Cabozantinib S-Malate	11	330	$286,137
Lenalidomide	Lenalidomide	23	623	$266,705

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	30	$1,091
J9190	Injection, fluorouracil, 500 mg	N	N/R	30	$596
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	29	$556

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Abdullateef Abdulkareem, M.D.?

Tedicare shows public-source Medicare data for Abdullateef Abdulkareem, M.D. (NPI 1386027068), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abdullateef Abdulkareem, M.D. have ACO affiliation data?

Abdullateef Abdulkareem, M.D. is shown with ACO affiliation data for Lancaster General Health Community Care Collaborative, LLC (MSSP, ACO ID A2019).

What billing organization is linked to Abdullateef Abdulkareem, M.D.?

Abdullateef Abdulkareem, M.D. is linked to LANCASTER GENERAL MEDICAL GROUP (billing NPI 1376526152) in the available physician profile data.

Does Abdullateef Abdulkareem, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.